State facing more ‘avoidable deaths’ unless superbugs dealt with
HSE urges Government to prioritise tackling antibiotic resistant bacteria called CPE
The HSE is seeking nearly €8m in additional funding to allow it to recruit about 80 key personnel such as microbiologists and laboratory staff to deal with the threat. File image: iStock
New superbugs are leading to avoidable deaths in hospitals across the State and could undermine the sustainability of the entire healthcare system if not tackled, the head of the HSE has warned the Government.
In correspondence seen by The Irish Times, Tony O’Brien urged the Government to immediately direct health chiefs to prioritise tackling healthcare associated infections and antimicrobial resistance.
Mr O’Brien said the biggest concern was a group of antibiotic resistant bacteria known as CPE. He said the incidence of CPE was growing rapidly.
He warned Minister for Health Simon Harris that tackling the spread of superbugs in hospitals could clash with plans to deal with overcrowding in emergency departments this winter.
The HSE was seeking nearly €8 million in additional funding to allow it to recruit about 80 key personnel such as microbiologists and laboratory staff to deal with the threat, he added.
The letter came in advance of Mr Harris announcing the convening of the National Public Health Emergency Team yesterday to respond to the bug.
Human infections with CPE are associated with poorer patient outcomes and mortality rates exceeding 40-50 per cent, and higher hospital costs. The bug carbapenemase-producing enterobacteriaceae (CPE), also referred to as carbapenem-resistant enterobacteriaceae (CRE), is the newest “superbug” that is hard to kill with antibiotics.
Mr O’Brien warned: “If we do not effectively balance actions to pre-empt winter pressures and actions to control the spread of healthcare associated infections, we will continue to have avoidable deaths; we will continue to have outbreaks in our acute hospitals which will result in closures of hospitals to elective admissions.”
His letter added: “The challenge has now escalated to a new level with the first detection in a hospital in Ireland in June 2017 of a CPE that also carries a gene called MCR. This CPE bacteria is also resistant to colistin which has become one of the few antibiotics that we have been able to rely on for the treatment of CPE.”